Kamis, 27 September 2012

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Bristol, UK, Sydney and Newcastle, Australia (PRWEB UK) 4 April 2012 Abcam, together with The University of Newcastle and the Children s Medical Researc

Bristol, UK, Sydney and Newcastle, Australia (PRWEB UK) 4 April 2012

Abcam, together with The University of Newcastle and the Children's Medical Research Institute, have today announced the expansion of their range of small molecule dynamin inhibitors for research. These are novel tools for investigating clathrin-mediated endocytosis and synaptic vesicle recycling and are available in the Abcam Biochemicals range. The agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company.

Related video about Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

The Multiple Futures of Gender and Sexuality Studies

The Multiple Futures of Gender and Sexuality Studies currently completing a new book on queer performance between the religious and secular Shes also editor of the Sexual Cultures book series Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Tidak ada komentar:

Posting Komentar